LGT Group Foundation’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LGT Group Foundation's BMY Position: Q2 2026 in Review
LGT Group Foundation reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q2 2026, selling an estimated $31.9K and leaving 19,269 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #186.
LGT Group Foundation first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $43.4M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- LGT Group Foundation held 19,269 shares of Bristol-Myers Squibb worth $1.11M as of Q2 2026.
- LGT Group Foundation sold 555 Bristol-Myers Squibb shares in Q2 2026, an estimated $31.9K.
- Bristol-Myers Squibb made up 0.01% of LGT Group Foundation's portfolio in Q2 2026, its #186 holding.
- LGT Group Foundation first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- LGT Group Foundation's Bristol-Myers Squibb position peaked at $43.4M in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.